Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: XOMA Acquires Royalty Interest in Four Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance

J Davenport over at Stockhouse sumed it up pretty much the Bioasis/XOMA agreement of 2019. For XOMA to dish out $1.2 Mil at this stage of the game is a plus for Bioasis. They need to take cash where they can find it, now. 

IMO ... Koo

 

Share
New Message
Please login to post a reply